GCF MMP-8 levels in smokers and non-smokers with chronic periodontitis following scaling and root planing accompanied by systemic use of flurbiprofen

Journal of Periodontology

Volumn 78, Issue 10, 2007, Pages 1954-1961

  Kurtis, Bülent ^a   Tüter, Gülay ^a   Serdar, Muhittin ^b   Pinar, Selin ^a   Demirel, Ilkim ^a   Toyman, Utku ^a  

^a GAZI UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Chronic periodontitis; Flurbiprofen therapeutic use; Gingival crevicular fluid; Matrix metalloproteinase 8; Smoking

Indexed keywords

FLURBIPROFEN; NEUTROPHIL COLLAGENASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYMOLOGY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PERIODONTITIS; PREVENTIVE DENTISTRY; SINGLE BLIND PROCEDURE; SMOKING;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; DENTAL SCALING; FEMALE; FLURBIPROFEN; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MIDDLE AGED; PERIODONTITIS; SINGLE-BLIND METHOD; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 35648956772     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.070149     Document Type: Article

References (49)

1. Ingman T, Sorsa T, Michaelis J, Konttinen YT. Immunohistochemical study of neutrophil and fibroblast-type collagenases and stromelysin-1 in adult periodontitis. Scand J Dent Res 1994;102:342-349.
2. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodontol 1993;64:474-484.
3. Woolley DE, Davies RM. Immunolocalization of collagenase in periodontal tissues. J Periodontal Res 1981;16:292-297.
4. Seltzer JL, Adams SA, Grant GA, Eisen AZ. Purification and properties of a gelatin-specific neutral protease from human skin. J Biol Chem 1981;256:4662-4668.
5. Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H, Larjava H. Transforming growth factor-β1 upregulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 1991;266:11436-11441.
6. Kalebic T, Garbisa S, Glaser B, Liotta LA. Basement membrane collagen: Degradation by migrating endothelial cells. Science 1983;221:281-283.
7. Sorsa T, Ding YL, Ingman T, et al. Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol 1995;22:709-717.
8. Sorsa T, Tjaderhane L, Salo T. Matrix metalloproteinases (MMPs) in oral diseases. Oral Dis 2004;10:311-318.
9. Sorsa T, Uitto VJ, Suomolainen M, Vauhkonen M, Lindy S. Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. J Periodontal Res 1988;23:386-393.
10. Söder B, Airila Mansson S, Söder P-Ö, Kari K, Meurman J. Levels of matrix metalloproteinases-8 and -9 with simultaneous presence of periodontal pathogens in gingival crevicular fluid as well as matrix metalloproteinase-9 and cholesterol in blood. J Periodontal Res 2006;41:411-417.
11. Buduneli N, Vardar S, Atilla G, Sorsa T, Luoto H, Baylas H. Gingival crevicular fluid matrix metalloproteinase-8 levels following adjunctive use of meloxicam and initial phase of periodontal therapy. J Periodontol 2002;73:103-109.
12. Golub L, Lee H, Greenwald R, et al. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflamm Res 1997;46:310-319.
13. Howell TH, Williams RC. Nonsteroidal anti-inflammatory drugs as inhibitors of periodontal disease progression. Crit Rev Oral Biol Med 1993;4:177-196.
14. Offenbacher S, Braswell LD, Loos AS, et al. Effects of flurbiprofen on the progression of periodontitis in Macaca mulatta. J Periodontal Res 1987;22:473-481.
15. Pelletier JP, Pelletier JM. Effects of nimesulide and naproxen on the degradation and metalloproteinase synthesis of human osteoarthritic cartilage. Drugs 1993;(Suppl. 1):34-39.
16. Barracchini A, Franceschini N, Minisola G, et al. Meloxicam and indomethacin activity on human matrix metalloproteinases in synovial fluid. Ann N Y Acad Sci 1999;878:665-666.
17. Williams RC, Jeffcoat MK, Howell TH, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-490.
18. Salmon JA, Simmons PM, Moncada S. The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation. J Pharm Pharmacol 1983;35:808-813.
19. Allison AC, Chin RC, Cheng Y. Cycloxygenase inhibitors vary widely in potency for preventing cytokine-induced bone resorption. Ann N Y Acad Sci 1993;696:303-306.
20. Kinane DF, Chestnutt IG. Smoking and periodontal disease. Crit Rev Oral Biol Med 2000;11:356-365.
21. Apatzidou DA, Riggio MP, Kinane DF. Impact of smoking on the clinical, microbiological and immunological parameters of adult patients with periodontitis. J Clin Periodontol 2005;32:973-983.
22. Preber H, Bergström J, Linder LE. Occurrence of periopathogens in smoker and non-smoker patients. J Clin Periodontol 1992;19:667-671.
23. Stoltenberg JL, Osborn JB, Pihlström BL, et al. Association between cigarette smoking, bacterial pathogens, and periodontal status. J Periodontol 1993;64:1225-1230.
24. Zambon JJ, Grossi SG, Machtei EE, Ho AW, Dunford R, Genco RJ. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens. J Periodontol 1996;67:1050-1054.
25. Ryder MI, Fujitaki R, Johnson G, Hyun W. Alterations of neutrophil oxidative burst by in vitro smoke exposure: Implications for oral and systemic diseases. Ann Periodontol 1998;3:76-87.
26. Selby C, Drost E, Brown D, Howie S, MacNee W. Inhibition of neutrophil adherence and movement by acute cigarette smoke exposure. Exp Lung Res 1992;18:813-827.
27. Giannopoulou C, Cappuyns I, Mombelli A. Effect of smoking on gingival crevicular fluid cytokine profile during experimental gingivitis. J Clin Periodontol 2003;30:996-1002.
28. Liu KZ, Hynes A, Man A, Alsagheer A, Singer DL, Scott DA. Increased local matrix metalloproteinase-8 expression in the periodontal connective tissues of smokers with periodontal disease. Biochim Biophys Acta 2006;1762:775-780.
29. Liede KE, Haukka JK, Hietanen JHP, Matilla MH, Rönka H, Sorsa T. The association between smoking cessation and periodontal status and salivary proteinase levels. J Periodontol 1999;70:1361-1368.
30. 2 in gingival crevicular fluid in matched clinical sites in smokers and non-smokers with persistent periodontitis. J Clin Periodontol 2002;29:384-391.
31. Kaldahl WB, Johnson GK, Patil KD, Kalkwarf KL. Levels of cigarette consumption and response to periodontal therapy. J Periodontal 1996;67:675-681.
32. Grossi SG, Zambon J, Machtei EE, et al. Effects of smoking and smoking cessation on healing after mechanical periodontal therapy. J Am Dent Assoc 1997;128:599-607.
33. Machion L, Andia DC, Lecio G Jr., et al. Locally delivered doxycycline as an adjunctive therapy to scaling and root planing in the treatment of smokers: A 2-year follow-up. J Periodontol 2006;77:606-613.
34. Palmer RM, Matthews JP, Wilson RF. Non-surgical periodontal treatment with and without adjunctive metronidazole in smokers and non-smokers. J Clin Periodontol 1999;26:158-163.
35. Tomasi C, Wennström JL. Locally delivered doxycycline improves the healing following non-surgical periodontal therapy in smokers. J Clin Periodontol 2004;31:589-595.
36. 2 and thiobarbituric acid reactive substance levels in smokers and non-smokers with chronic periodontitis following phase I periodontal therapy and adjunctive use of flurbiprofen. J Periodontol 2007;78:104-111.
37. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and oral condition. Acta Odontol Scand 1964;22:121-135.
38. Löe H. The gingival index, plaque index, and the retention index systems. J Periodontol 1967;38:610-616.
39. Griffiths GS, Curtis MA, Wilton JM. Selection of a paper with optimum properties for the collection of gingival crevicular fluid. J Periodontal Res 1988;23:33-38.
40. Hotz G. Drug therapy of post-operative and posttraumatic edema (in German). ZWR 1986;95:256-261.
41. van der Weijden GA, De Siegte C, Timmerman MF, van der Velden U. Periodontitis in smokers and non-smokers: Intra-oral distribution of pockets. A retrospective study. J Clin Periodontol 2001;28:955-960.
42. Boström L, Linder LE, Bergström J. Smoking and GCF levels of IL-1β and IL-1ra in periodontal disease. J Clin Periodontal 2000;27:250-255.
43. 2, and matrix metalloproteinase-8 in refractory periodontitis sites in smokers and non-smokers. Acta Odontol Scand 1999;57:77-82.
44. Heasman L, Stacey F, Preshaw PM, McCracken GI, Hepburn S, Heasman PA. The effect of smoking on periodontal treatment response: A review of clinical evidence. J Clin Periodontol 2006;33:241-253.
45. Pucher JJ, Shibley O, Dentino AR, Ciancio SG. Results of limited initial periodontal therapy in smokers and non-smokers. J Periodontol 1997;68:851-856.
46. Zuabi O, Machtei EE, Ben-Aryeh H, Ardekian L, Peled M, Laufer D. The effect of smoking and periodontal treatment on salivary composition in patients with established periodontitis. J Periodontol 1999;70:1240-1246.
47. Preshaw PM, Hefti AF, Bradshaw MH. Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontal 2005;32:610-616.
48. Greenwald RA, Moak SA, Ramamurthy NS, Golub LM. Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen, ameliorate bone damage. J Rheumatol 1992;19:927-938.
49. Lee HM, Ciancio SG, Tüter G, Ryan ME, Komaroff E, Golub LM. Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J Periodontol 2004;75:453-463.